Evidence map›Paper›PMID 37675101›Full record

ArticleFrontiers in immunology2023

Identification of Vancomycin Resistance in Methicillin-resistant

Rachele M Bochart, Kimberly Armantrout, Hugh Crank, Rachael Tonelli, Christine Shriver-Munsch, Tonya Swanson, Miranda Fischer, Helen Wu, Michael Axthelm, Jonah Sacha and 1 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. CcpA promotesmLife · 2025
    Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Rachele M BochartVaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR, United States.
Kimberly ArmantroutVaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR, United States.
Hugh CrankVaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR, United States.
Rachael TonelliVaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR, United States.
Christine Shriver-MunschDivision of Pathobiology and Immunology, Oregon National Primate Research Center, Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR, United States.
Tonya SwansonDivision of Pathobiology and Immunology, Oregon National Primate Research Center, Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR, United States.
Miranda FischerVaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR, United States.
Helen WuDivision of Pathobiology and Immunology, Oregon National Primate Research Center, Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR, United States.
Michael AxthelmDivision of Pathobiology and Immunology, Oregon National Primate Research Center, Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR, United States.
Jonah SachaDivision of Pathobiology and Immunology, Oregon National Primate Research Center, Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR, United States.
Jeremy V SmedleyVaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR, United States.
Children's Cancer Therapy Development Institute · USOregon Health & Science University · USOregon National Primate Research Center · US

Funding

Upgrade of confocal microscopy at the Oregon National Primate Research CenterP51OD011092 · OD · OREGON HEALTH & SCIENCE UNIVERSITY · PI Bonnie J. Nagel · 2012 to 2026
$203.9M
A nonhuman primate model of stem cell transplantation to understand determinants of post-transplant SIV clearanceR01AI129703 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI SACHA, JONAH B. · 2017 to 2025
$7.8M
NIAID NIH HHS R01 AI129703NIH HHS P51 OD011092
6 · The paper itself

Abstract

Methicillin-resistant

Indexed as

Methicillin-Resistant Staphylococcus aureusAnimalsHumansMacaca fascicularisMacaca mulattaStaphylococcus aureusVancomycinVancomycin ResistanceVancomycinantibiotic resistancecynomolgus macaquesdecolonizationmethicillin-resistant Staphylococcus aureusmupirocinoccupational safetyrhesus macaquesvancomycin- resistant Staphylococcus aureus

Identifiers

PMID37675101
PMCPMC10477669
OpenAlexW4386069056

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.